Abstract-Numerous studies addressed the predictive value of the nighttime blood pressure (BP) as captured by ambulatory monitoring. However, arbitrary cutoff limits in dichotomized analyses of continuous variables, data dredging across selected subgroups, extrapolation of cross-sectional studies to prospective outcomes, and lack of comprehensive adjustments for confounders make interpretation of the literature difficult. We reviewed prospective studies with total mortality or a composite cardiovascular end point as an outcome in relation to the level and the circadian profile of systolic BP. We analyzed studies in hypertensive patients (nϭ23 856) separately from those in individuals randomly recruited from populations (nϭ9641). We pooled summary statistics and individual subject data, respectively. In both patients and populations, in analyses in which nighttime BP was additionally adjusted for daytime BP and vice versa, nighttime BP was a stronger predictor than daytime BP. With adjustment for the 24-hour BP, both the night-to-day BP ratio and dipping status remained significant predictors of outcome but added little prognostic value over and beyond the 24-hour BP level. In the absence of conclusive evidence proving that nondipping is a reversible risk factor, the option whether or not to restore the diurnal blood pressure profile to a normal pattern should be left to the clinical judgment of doctors and should be individualized for each patient. Current guidelines on the interpretation of ambulatory BP recording need to be updated. (Hypertension. 2011;57:00-00.) • Online Data Supplement Key Words: ambulatory blood pressure monitoring Ⅲ dipping status Ⅲ nighttime blood pressure Ⅲ night-to-day blood pressure ratio Ⅲ population science Ⅲ risk factors A mbulatory monitoring enables recording the blood pressure throughout the entire day, while subjects engage in their usual day-to-day activities. 1,2 The diurnal blood pressure profile normally includes a 10% to 20% fall in blood pressure during sleep, which is driven by physical inactivity and which is largely independent of an endogenous rhythm. 3 Indeed, in shift workers, the 24-hour blood pressure level and the fall in blood pressure during sleep were similar on days with daytime and nighttime work. 3 In 1988, O'Brien et al 4 reported for the first time that patients with an abnormal circadian blood pressure profile with a less marked decrease in the nighttime blood pressure had a more frequent history of stroke. O'Brien and colleagues thereby coined the terms dipping versus nondipping. Subsequent studies of hypertensive cohorts 5-24 and populations [25][26][27][28][29][30] did not all 8,15,18,26,30 corroborate the worse prognosis associated with a high nighttime blood pressure. Moreover, interpretation of these studies is not always easy. First, positive results based on arbitrary and varying definitions of nondipping were sometimes not supported by analysis of the nocturnal blood pressure fall as a continuous variable. 7,15 Second, in some reports significant results were only obtained in arbitrarily selected subgroups. 11,18 Third, most studies had a crosssectional design (see supplemental Table S1 available at http://hyper.ahajournals.org), which according to Hill's 31 criteria is a weak source of evidence to establish causality. Finally, the associations of outcome with nighttime blood pressure 8,9,17,19,20 or with dipping status 15,19 often stayed unadjusted for the daytime or 24-hour blood pressure level, respectively.
A mbulatory monitoring enables recording the blood pressure throughout the entire day, while subjects engage in their usual day-to-day activities. 1, 2 The diurnal blood pressure profile normally includes a 10% to 20% fall in blood pressure during sleep, which is driven by physical inactivity and which is largely independent of an endogenous rhythm. 3 Indeed, in shift workers, the 24-hour blood pressure level and the fall in blood pressure during sleep were similar on days with daytime and nighttime work. 3 In 1988, O'Brien et al 4 reported for the first time that patients with an abnormal circadian blood pressure profile with a less marked decrease in the nighttime blood pressure had a more frequent history of stroke. O'Brien and colleagues thereby coined the terms dipping versus nondipping. Subsequent studies of hypertensive cohorts [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] and populations [25] [26] [27] [28] [29] [30] did not all 8, 15, 18, 26, 30 corroborate the worse prognosis associated with a high nighttime blood pressure. Moreover, interpretation of these studies is not always easy. First, positive results based on arbitrary and varying definitions of nondipping were sometimes not supported by analysis of the nocturnal blood pressure fall as a continuous variable. 7, 15 Second, in some reports significant results were only obtained in arbitrarily selected subgroups. 11, 18 Third, most studies had a crosssectional design (see supplemental Table S1 available at http://hyper.ahajournals.org), which according to Hill's 31 criteria is a weak source of evidence to establish causality. Finally, the associations of outcome with nighttime blood pressure 8, 9, 17, 19, 20 or with dipping status 15, 19 often stayed unadjusted for the daytime or 24-hour blood pressure level, respectively.
This review is an attempt to derive more precise estimates for the association between outcome and the ambulatory blood pressure during sleep as reflected by the nocturnal blood pressure level, the night-to-day blood pressure ratio, or dipping status. In our systematic review, we only included prospective cohort studies of hypertensive patients or randomly selected population samples. We evaluated the influence of accounting for blood pressure level on the associations between outcome and indexes derived from the circadian blood pressure profile.
Search Strategy and Statistical Methods
We based our analyses of cohorts of hypertensive patients and population studies on summary statistics and individual subject data, respectively. For both patients and populations, we limited our analyses to systolic blood pressure, because at middle and older age this is the predominant risk factor. 32 Search methods, selection of studies, and statistical methods are described in detail in the supplemental Methods available online. Figure 1 shows the articles retrieved, reviewed, and included in the analysis of cohorts of hypertensive patients. Table 1 lists the characteristics of the studies reporting on outcome in patient cohorts. Studies included from 104 11 to 5292 5 patients (median 809). All studies enrolled hypertensive participants of either sex with the proportion of women ranging from 13% 11 to 71% 18 (median 52%). Chronic kidney disease and diabetes mellitus were comorbid conditions in 1 16 and 3 11, 15, 19 studies, respectively. Mean age at enrollment ranged from 51 8 to 73 16 years. Ethnicity was white in 8 studies, 5,6,9 -11,13,17,20 Japanese in 3 7, 15, 16 studies, and mixed in 5 studies. 8, 12, 14, 18, 19 The technique of ambulatory blood pressure measurement was exclusively 5, 7, 10, [12] [13] [14] 16, 17, 19, 20 or predominantly 6, 9, 11, 15, 18 oscillometric in all but 1 study, 8 in which blood pressure was measured intra-arterially. In the studies that used an intermittent technique, the interval between readings ranged from 15 10, 11, 13, 14, 18, 20 to 30 [5] [6] [7] 9, [15] [16] [17] minutes during daytime and from 15 13 to 60 9 minutes during nighttime. Of the reviewed studies, 6 implemented a diary to differentiate awake from asleep blood pressures, 7, 12, 15, 16, 18, 19 while 4 and 6 studies used long 7, 11, 14, 20 or short 5, 6, 9, 10, 13, 17 fixed clock-time intervals, respectively.
Studies in Hypertensive Patients
Total mortality was available from 11 studies. 5-7,9,11-14,18 -20 Nine studies 6,8 -10,13,15-18 reported on a composite cardiovascular end point that always included cardiovascular mortality, myocardial infarction, and stroke. In some studies, the composite end point also encompassed coronary revascularization, 8 ,17,18 cardiac surgery, 13 or heart failure. 6,9,13,18 Follow up ranged from 3.4 7, 16 to 10.9 10 years (median 5.9). All studies considered sex and age as confounders with the exception of one with 52% women, 14 in which the hazard ratio was only adjusted for age but not sex. The other covariables, in order of frequency, were smoking in 12 studies, 5,6,8 -10,13,15-20 diabetes mellitus in 10 studies, 5,8 -10,12,13,16 -20 body mass index in 9 studies, 5, 7, 9, 10, [15] [16] [17] [18] 20 serum cholesterol in 9 studies, 8 -10,13,16 -20 antihypertensive treatment in 8 studies, 6,7,10,12,16 -18,20 previous cardiovascular disease in 7 studies, 5,6,8,9,18 -20 and/or an index of renal function in 6 studies. 11,14,16,18 -20 All 5-13,15-20 but 1 study 14 included in our quantitative review considered multiple confounders. All studies had a prospective design with blinded end point adjudication against source documents. The median impact factor of the journals at the time of publication was 6.3 (range 2.4 to 34.8).
The supplemental Results and Tables S2 and S3 list the hazard ratios as extracted from published papers [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] or as provided by the principal investigators. 7, 10, 13, 16 They express the risk associated with a 10-mm Hg increase in the nighttime or daytime systolic blood pressure, with a 10% increase in the systolic night-to-day blood pressure ratio, or with systolic nondipping as defined in each publication (Table S4) . Multivariable-adjusted pooled estimates that combined the statistics from available studies showed that the nighttime and daytime blood pressures, the night-to-day blood pressure ratio, and the dipping status were all significant predictors of total mortality and cardiovascular outcome (Figure 2A ). However, fully adjusted pooled statistics that accounted for nighttime as well as daytime blood pressure in the same model were significant only for nighttime blood pressure, whereas daytime blood pressure lost its prognostic value. The hazard ratios associated with each 10-mm Hg increment in the nighttime blood pressure were 1.16 for total mortality and 1.19 for cardiovascular events ( Figure 2B ). In fully adjusted models, which in addition to the night-to-day blood pressure ratio or dipping status also included the 24-hour blood pressure, both indexes based on the diurnal blood pressure profile retained significance with the exception of the night-to-day blood pressure ratio as predictor of total mortality ( Figure 2B ).
Population Studies
Of 11 790 subjects available in the IDACO (International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes) database, we excluded 2149 (18.2%), because their daytime (nϭ169) or nighttime (nϭ1951) blood pressure had not been measured or were averages of fewer than 10 or 5 readings, respectively, or because the participants were less than 18 years old at the moment of enrollment (nϭ29). Thus, the number of subjects statistically analyzed totaled 9641. For the present analysis, participants recruited for the European Project on Genes in Hypertension in Novosibirsk (nϭ244), Pilsen (nϭ165), Padova (nϭ310), and Kraków (nϭ308) were combined. Table 2 lists the characteristics of the population cohorts. Studies included from 351 33 to 2142 26 subjects (median 1114). One study 30 included only men. In the other studies, the proportion of women ranged from 48% 26 to 63% 34 (median 54%). Mean age at enrollment ranged from 36 35 to 71 30 years. Ethnicity was white in 5 studies 26, 30, [35] [36] [37] and Asian in 2 studies, 33,34 while 1 study 38 included South Americans. The technique of ambulatory blood pressure measurement was auscultatory (Accutracker II) in 1 study 30 and oscillometric (SpaceLabs 90202 and 90207, Nippon Colin, and ABPM-630) in all other cohorts. 26, [33] [34] [35] [36] [37] [38] In each cohort, outcomes were adjudicated against source documents, as described in previous publications. 26, 30, 33, 34, [37] [38] [39] [40] The composite cardiovascular end point included cardiovascular mortality, nonfatal myocardial infarction, coronary revascularization, heart failure, and stroke. Follow up ranged from 2.5 33 to 17.6 37 years (median 11.2 years).
The supplemental Results and Tables S5 and S6 list the hazard ratios for total mortality and for the combined cardiovascular end point in the individual populations. The multivariable-adjusted models, combining all population cohorts, showed that the nighttime and daytime blood pressures, the night-to-day blood pressure ratio, and the dipping status were all significant predictors of total mortality and cardiovascular outcome ( Figure 3A) . Fully adjusted models, which accounted for nighttime as well as daytime blood pressure, revealed that the level of nighttime blood pressure remained a significant predictor of both outcomes. The hazard ratios associated with each 10-mm Hg increment in the nighttime blood pressure were 1.14 for total mortality and 1.15 for cardiovascular events ( Figure 3B ). In these models, the daytime blood pressure lost its prognostic value for total mortality but remained a significant predictor of the composite cardiovascular outcome. In fully adjusted models, which in addition to the night-to-day blood pressure ratio or dipping status also included the 24-hour blood pressure, both indexes based on the diurnal blood pressure profile retained significance with the exception of dipping status as predictor of cardiovascular events ( Figure 3B ). TM/CVE indicates number of deaths/cardiovascular events; FU, average follow-up duration in years; ABPM, ambulatory blood pressure monitoring; E, ethnicity; S, sex; A, age; OBP, office blood pressure; OHR, heart rate in the office; BMI, body mass index; SMK, smoking; PA, level of physical activity; CHL, serum cholesterol; RF, index of renal function, such as serum creatinine or micro-albuminuria; HRV, heart rate variability; AHT, antihypertensive drug treatment; CVD, history of cardiovascular disease; DM, diabetes mellitus; Rx, group of randomization.
Interpretation of the Evidence
This systematic review revealed that systolic nighttime blood pressure was a stronger predictor than systolic daytime blood pressure in hypertensive patients as well as in subjects randomly selected from populations in Asia, Europe, and South America. The night-to-day blood pressure ratio and dipping status remained significant predictors of outcome, even with adjustments applied for the 24-hour blood pressure level in addition to other covariables. There was a striking similarity between the findings in hypertensive patients and populations. For a correct interpretation and clinical application of these findings, several issues need careful consideration.
Why Should Nighttime Blood Pressure be a Better Predictor?
Various hypothetical mechanisms support the plausibility of an enhanced cardiovascular risk associated with an increased night-to-day blood pressure ratio or higher nighttime blood pressure, such as alterations in the sympathetic modulation of In case of significant heterogeneity, pooled HRs were computed from random-effect models and otherwise from fixed-effect models. N S , N E , and N AR indicate the number of studies, events, and subjects at risk. Q is the test statistic for heterogeneity. P Q and P indicate the significance of Q and HR, respectively. Adjusted and fully adjusted refer to the Cox models as reported in published papers or as provided by authors. A, Adjusted refers to the most extensively adjusted risk estimate reported. B, Fully adjusted refers to models in which risk estimates based on daytime blood pressure were additionally adjusted for nighttime blood pressure and vice versa, or in which risk estimates based on the night-to-day blood pressure ratio or dipping status were also adjusted for the 24-hour blood pressure. the nighttime blood pressure, 41 disturbed baroreflex sensitivity, 42 sleep apnea, 43 or an increased salt sensitivity necessitating a higher blood pressure at night to drive pressure natriuresis. 44, 45 Furthermore, in terms of physical and mental activity as well as body position, the nighttime blood pressure is better standardized than the daytime blood pressure. However, sleep quality 13 and nocturnal urination 46 are of importance. The tactile stimuli and noise produced by repeated cuff inflations may disturb sleep. 47 Manning et al 48 assessed sleep quality in 79 untreated subjects from a simple self-administered questionnaire. Ambulatory asleep systolic blood pressure and the proportion of nondippers was significantly lower in the group that reported good sleep than in those reporting intermediate or poor sleep (101 versus 108 versus 111 mm Hg and 5.9% versus 18.2% versus 13.8%, respectively). 48 Verdecchia et al 13 studied a cohort of 2934 initially untreated hypertensive patients. In the presence of sleep deprivation by Ն2 hours (nϭ399) during ambulatory monitoring, nighttime systolic blood pressure was significantly higher (124.6 versus 128.3 mm Hg) but lost its prognostic significance over 7 years of follow up of mortality and a composite cardiovascular end point. 13 Implications for Clinical Practice Our review speaks in favor of recording the ambulatory blood pressure during the entire day. However, in all population cohorts combined, once the 24-hour blood pressure was in the Cox model, the night-to-day blood pressure ratio and dipping status contributed only 0.1% to the explained variance 49 in the incidence of total mortality or the cardiovascular end point (Table 3) . Moreover, when the night-to-day blood pressure ratio or dipping status was first entered into the Cox model, without the 24-hour blood pressure level, they sometimes explained more of the variability in outcome than the 24-hour blood pressure (Table 3) . In previous analyses, 29 we demonstrated that daytime systolic pressure added to the prediction of total mortality by the nighttime systolic pressure in treated hypertensive patients, but not in untreated subjects. Higher daytime blood pressure was associated with lower mortality in treated patients but with higher cardiovascular risk in untreated subjects. 29 The systolic night-to-day blood pressure ratio, ad- Figure 3 . Prediction of total mortality and all cardiovascular events from ambulatory blood pressure measurements at baseline in population cohorts. Filled squares represent the hazard ratios (HR), and horizontal lines denote the 95% confidence interval (CI). All analyses included 9641 subjects representing 11 cohorts. Total mortality and all cardiovascular events amounted to 1320 and 1128 events, respectively. A, Adjusted refers to models stratified for cohort and adjusted for sex, age, body mass index, smoking and drinking, serum total cholesterol, history of cardiovascular disease, diabetes mellitus, and treatment with antihypertensive drugs. B, Fully adjusted refers to models in which risk estimates based on daytime blood pressure were additionally adjusted for nighttime blood pressure and vice versa, or in which risk estimates based on the night-to-day blood pressure ratio or dipping status were also adjusted for the 24-hour blood pressure.
justed for the 24-hour blood pressure level and other covariables conferred higher risk in older (Ն60 years) than younger subjects. 29 The variance explained by the 24-hour blood pressure and the indexes derived from the nighttime blood pressure in Cox models stratified for age and treatment status appear in the supplemental data (Tables S7 to S10 ). These tables not only confirmed our previous findings but also corroborated that the variance explained depends on the order in which various blood pressure components are added to the model. Chronotherapy 50 means timing the administration of antihypertensive drugs in such a way that the blood pressure is lowered over 24 hours, while preserving a normal dipping pattern. Hermida et al 51, 52 provided the proof of concept. The classification of patients according to the night-to-day blood pressure ratio heavily depends on arbitrary criteria, is poorly reproducible, 48, [53] [54] [55] and has a different prognostic meaning according to the outcome under study, 29 the prevailing 24-hour blood pressure level, 29 and treatment status. 29 Reverse dippers have the highest cardiovascular risk but die at an older age than do subjects with a normal dipping pattern, which raises the issue of reverse causality. 29 
How to Measure Daytime and Nighttime Blood Pressure?
The current US guidelines do not present any specific recommendation for definitions of daytime and nighttime blood pressure. 56 The European Society of Hypertension Working Group on Blood Pressure Monitoring 2003 57 stated that "one simple and popular method of determining the time of awakening and sleeping is to assess them from diary card entries." The diary should also provide information on physical activity, intake of medications, and special events that might explain a particular diurnal pattern. 58 Accelerometry allows distinguishing awake from asleep periods but is out of reach for most clinicians. One alternative is to use short fixed clock-time intervals, which eliminate the transition periods in the morning and evening during which the blood pressure rapidly changes in most subjects. 59 The daytime and nighttime blood pressures defined in this way approximate within 1 to 2 mm Hg to the awake and asleep blood pressures. 59 In defining the clock-time intervals, one should account for differences in lifestyle across different cultures. 29 Although the last European guideline recommends that proportionally to the duration of daytime and nighttime the number of valid blood pressure readings should be similar, 58 it is common practice to space the readings at a greater interval during the night in order not to impair sleep quality. 13 It is therefore important to weigh the mean of the 24-hour blood pressure by the intervals between readings.
Limitations of Our Review
The present results have to be interpreted within the context of their limitations. First, in our review of studies of hypertensive patients, we could not address the potential methodological limitations of the original studies. In particular, we had to accept that the estimates of risk accounted for different sets of covariables. We could not retrieve all missing information from the principal investigators of original studies. Aggregate-level analyses of summary statistics have less power than an analysis of pooled individual subject data. 60 Nevertheless, our results from both types of meta-analyses, in hypertensive patients and populations, respectively, were remarkably similar. Second, individual studies in patients varied greatly with respect to the demographic characteristics of the participants and methodology, resulting in significant heterogeneity. We addressed this issue by computing pooled estimates from random-effect models. Third, we included only from 2 up to 7 studies in our review of data in hypertensive patients. This number of studies is small compared to the vast literature and did not allow us to check for publication bias in a reliable way. On the other hand, limiting our analyses to prospective studies is a strong point. The systematic and quantitative nature of our review also avoids bias in the selection of studies and the computation of pooled estimates. Finally, neither in hypertensive patients nor in populations could we account for physical activity during ambulatory monitoring or for antihypertensive treatment after enrollment. 
Perspectives
Our review identified several gaps in our current knowledge and therefore sets an agenda for researchers and experts writing guidelines. Further prospective studies should clarify the influence of treatment and age on the predictive value of the nighttime compared to the 24-hour or daytime blood pressure. Based on Hill's 31 criteria, such observational studies should exclude the issue of reverse causality. Because classification of patients according to the night-to-day blood pressure ratio greatly depends on arbitrary criteria and because it is poorly reproducible, we suggest that in future publications any categorical representation of the night-today blood pressure ratio be supported by continuous analyses adjusted for the 24-hour blood pressure.
Our current findings highlight the necessity to translate statistical parameters into clinically meaningful recommendations. By tradition, clinicians reason first in terms of blood pressure level rather than diurnal blood pressure profile. Properly designed randomized clinical trials should prove the reversibility of the risk associated with a nondipping blood pressure profile. In the absence of conclusive evidence proving that nondipping is a reversible risk factor, the option whether or not to restore the diurnal blood pressure profile to a normal pattern should be left to the clinical judgment of doctors and be individualized for each patient. Expert committees might draft new recommendations to help clinicians apply current knowledge in their day-to-day practice.
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Expanded Methods
Search Strategy and Statistical Methods
We based our analyses of cohorts of hypertensive patients and population studies on summary statistics and individual subject data, respectively. For both patients and populations, we limited our analyses to systolic blood pressure, because at middle and older age this is the predominant risk factor. 1
Cohorts Studies of Hypertensive Patients
To identify studies of hypertensive patients, in March 2010, we searched the PubMed database (http://www.ncbi.nlm.nih.gov/sites/entrez) for publications in English without any restraint on the year of publication. Starting from the preview/index tab, we choose as search terms for titles and abstracts: "dipping", "daytime", or "nighttime" in combination with "hypertension", "risk", or "mortality". Eligible studies had to be prospective. Enrolled patients had to be 18 years or older. We only considered studies, in which the ambulatory blood pressure was recorded outside the hospital. Required endpoints were total mortality and/or a composite of fatal and nonfatal cardiovascular events. We manually checked the reference lists of fully reviewed papers for articles not found by the PubMed search. When relevant information was not included in the published papers, we requested additional data from the senior authors. Our initial search identified 169 articles for possible inclusion in the systematic review of hypertensive cohorts (Figure 1 ). Of these, we excluded 145 on initial screen of the abstract because of a cross-sectional design (Table S1 ). The remaining 24 articles were fully reviewed. By checking the reference lists, we found 4 additional studies. [2] [3] [4] [5] On the other hand, we excluded 12 reports of longitudinal cohort studies, because the eligibility criteria were not met 6-9 (n=4) or because the same patients had been included in more than one report [10] [11] [12] [13] [14] [15] [16] [17] (n=8). In the latter case, we used the publication with the most complete information. The articles were ordered by year of publication and the name of the first author, given a unique identification number, and entered into a dedicated literature database, using Reference Manager, version 12.0.1 (Thomson Reuters; http://www.refman.com). One investigator (T.W.H.) read all papers, extracted, and computerized the relevant information, and provided copies of the papers to the senior author (J.A.S.), who checked the data extraction and summary statistics. Inconsistencies were discussed until a unanimous interpretation of the source data was reached. As measures of quality control, we considered blinded endpoint ascertainment, adjustments applied in regression analysis, and the impact factor of the journal at the time of publication of each reviewed article. 18 We used SAS software (SAS Institute Inc., Cary, NC) for entering the extracted summary statistics into a database for subsequent statistical analysis. In our analyses, we used adjusted and fully adjusted hazard ratios as reported in published papers or as provided by authors on our request. Adjusted refers to the most extensively adjusted risk estimate reported. Fully adjusted refers to Cox models, in which risk estimates based on daytime blood pressure were additionally adjusted for nighttime blood pressure and vice versa, or in which risk estimates based on the night-to-day blood pressure ratio or dipping status were also adjusted for the 24-h blood pressure.
We used the PROC MIXED procedure of the SAS package and the method of moments to compute pooled estimates of the hazard ratios as extracted from published papers or as provided by the authors. 19 Pooled hazard ratios were weighted by the inverse of the variance in individual studies. We assessed the null-hypothesis of homogeneity across individual studies by the Q test. 19 In case of significant heterogeneity, pooled hazard ratios were computed from random effect models and otherwise from fixed effect models.
Prospective Population Studies
For the population studies, we did an electronic search of the English literature, using as search terms "ambulatory blood pressure", "population", "mortality", and "morbidity", which identified 14 prospective studies. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] As described in detail elsewhere, we constructed the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO). 32 Studies were eligible for inclusion if they included a random population sample, if information about the conventional and ambulatory blood pressures and cardiovascular risk factors were available at baseline, and if the subsequent follow-up included both fatal and nonfatal outcomes. We excluded the Maracaibo Aging Study 22 and the Jackson Heart Study, 23 because at the time of writing this review outcome data had not yet been made available for inclusion into the IDACO database. The Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 21 was omitted, because only fatal outcomes were available.
Our systematic review of population studies was a meta-analysis of individual subject data. The same SAS macro processed all ambulatory recordings, which generally stayed unedited. The Ohasama recordings were edited sparsely according to previously published criteria. 33 While accounting for the daily pattern of activities of the participants, we defined daytime as the interval from 10 AM to 8 PM in Europeans 20, 24, 31 and South Americans, 29 and from 8 AM to 6 PM in Asians. 27, 28 The corresponding nighttime intervals ranged from midnight to 6 AM 20,24,29,31 and from 10 PM to 4 AM, 27, 28 respectively. These fixed intervals eliminate the transition periods in the morning and evening when blood pressure changes rapidly, resulting in daytime and nighttime blood pressure levels that are within 1-2 mm Hg of the awake and asleep levels. 34 We weighted the individual means of the ambulatory blood pressure by the interval between readings. In dichotomous analyses, we defined nondipping as a night-to-day blood pressure ratio of 0.90 or higher.
We used Cox regression to compute hazard ratios. We checked the proportional hazards assumption by the Kolmogorov-type supremum test, as implemented in the PROC PHREG procedure of the SAS package and by testing the interaction terms between follow-up duration and either blood pressure or the night-to-day blood pressure ratio. In adjusted models, we stratified for cohort and we adjusted for sex, age, body mass index, smoking and drinking, serum total cholesterol, history of cardiovascular disease, diabetes mellitus, and treatment with antihypertensive drugs. Fully adjusted models for the daytime blood pressure additionally included the nighttime blood pressure, and vice versa, and for the night-to-day blood pressure ratio and the dipping status they additionally included the 24-h blood pressure. We applied the generalized R 2 statistic to assess the risks explained in Cox regression 35 by consecutively entering the 24-h blood pressure and indexes derived from the nocturnal blood pressure and vice versa as predictor variables into the models for total mortality and the cardiovascular endpoint.
Expanded Results
Studies in Hypertensive Patients
Nighttime Blood Pressure Total Mortality Across 6 studies 2,36-40 (Table S2) , the hazard ratio (HR) expressing the risk of death associated with the nighttime blood pressure as continuous variable ranged from 1.06 (P=0.11) 2 to 1.20 (P<0.0001). 40 Of these 7 HRs, 5 were significant. 36, [38] [39] [40] [41] The pooled HR combining these 7 studies (Figure 2, Panel A) was 1.15 (95% confidence interval [CI], 1.11-1.20; P<0.0001) . HRs with additional adjustment for the daytime blood pressure were available from 5 studies, 36, [38] [39] [40] 42 ranging from 1.03 (P=0.87) 42 to 1.21 (P=0.020). 36 Of these 5 fully adjusted HRs, 4 were significant. 36, [38] [39] [40] The pooled HR combining these 5 studies (Figure 2, Panel B) was 1.16 (CI, 1.12-1.22; P<0.0001 ). Cardiovascular Events Among 7 studies 4, 36, 37, 40, [43] [44] [45] (Table S3) , the HRs ranged from 1.10 (P=0.060) 43 to 1.31 (P=0.0001) 37 of which 6 were significant. 4, 36, 37, 40, 44, 45 The pooled HR (Figure 2 , Panel A) was 1.23 (CI, 1.18-1.28; P<0.0001). HRs with additional adjustment for the daytime blood pressure were available from 5 studies, 3, 4, 36, 40, 44 ranging from 1.00 (P=0.99) 3 to 1.26 (P=0.0010). 36 Of these 5 fully adjusted HRs, 3 were significant. 36, 40, 44 The pooled HR combining these 5 studies (Figure 2 , Panel B) was 1.19 (CI, 1.12-1.27; P<0.0001).
Daytime Blood Pressure Total Mortality
Among 5 studies [36] [37] [38] [39] [40] (Table S2) , the HRs expressing the risk of death associated with the daytime blood pressure ranged from 1.07 (P=0.39) 36 to 1.40 (P<0.0001). 41 Of these 6 HRs, 4 were significant. [38] [39] [40] [41] The pooled HR (Figure 2 (Table S3) , the HRs ranged from 1.10 (P=0.060) 43 to 1.42 (P=0.0001), 37 6 reaching significance. 4, 36, 37, 40, 44, 45 The pooled HR combining these 7 studies (Figure 2 , Panel A) was 1.23 (CI, 1.17-1.31; P<0.0001). HRs with additional adjustment for the nighttime blood pressure were available from 5 studies, 3, 4, 36, 40, 44 ranging from 0.94 (P=0.45) 36 to 1.14 (P=0.27). 4 Of these 5 fully adjusted HRs, none was significant. The pooled fully adjusted HR (Figure 2 , Panel B) was 1.06 (CI, 0.98-1.13; P=0.13).
Night-to-Day Blood Pressure Ratio
Total Mortality Across 4 studies 2, 5, 39, 40 (Table S2) , the HRs expressing the risk of death associated with the nightto-day blood pressure ratio ranged from 1.14 (P=0.16) 40 to 1.35 (P=0.027). 5 Of these 4 HRs, 3 were significant. 2, 5, 39 The pooled HR (Figure 2 , Panel A) was 1.19 (CI, 1.12-1.27; P<0.0001). HRs with additional adjustment for the 24-h blood pressure, available from 3 studies, 40, 46, 47 ranged from 1.06 (P=0.54) 40 to 1.63 (P=0.0020), 46 but only 1 was significant. 46 The pooled HR combining these 3 studies (Figure 2, Panel B 40, 44 (Table S3) 
Dipping Status
Total Mortality Across 3 studies 2, 39, 40 (Table S2) , the HRs expressing the risk of death associated with nondipping ranged from 1.25 (P=0.15) 40 to 1.45 (P=0.0017). 39 Of these 3 HRs, 2 were significant. 2, 39 The pooled HR combining 3 studies (Figure 2, Panel A) was 1.37 (CI, 1.17-1.61; P<0.0001) . HRs for the dipping status with additional adjustment for the 24-h blood pressure, available from 4 studies, 40, 42, 46, 47 ranged from 1.10 (P=0.80) 42 to 1.67 (P=0.075), 47 but only 1 reached significance. 46 The pooled fully adjusted HR (Figure 2, Panel B (Table S3) , the HRs expressing the cardiovascular risk associated with nondipping were 1.15 (P=0.66) 4 to 1.36 (P=0.0060). 40 The pooled HR (Figure 2 
Studies in Population Cohorts
Nighttime Blood Pressure Total Mortality In 11 cohorts (Table S5) , the HRs expressing the risk of death associated with the nighttime blood pressure ranged from 1.03 (P>0.46) 29,48 to 1.57 (P=0.0007). 28 Of these 11 HRs, 4 were significant. 27, 28, 31, 49 The HR combing all the cohorts (Figure 3 , Panel A) was 1.11 (CI, 1.07-1.16; P<0.0001). HRs with additional adjustment for the daytime blood pressure ranged from 1.04 (P=0.45) 48 to 1.73 (P=0.0017). 28 Of these 11 fully adjusted HRs, 4 were significant. 27, 28, 31, 49 The combined HR (Figure 3, Panel B 28 and 6 were significant (Table S6) . [27] [28] [29] 31, 48, 49 The HR combing all the cohorts (Figure 3 
Daytime Blood Pressure Total Mortality
The HRs expressing the risk of death associated with the daytime blood pressure ranged from 0.92 (P>0.64) 26 to 1.23 (P=0.21), 28 but only 2 were significant. 31, 49 The HR combining the 11 cohorts (Figure 3 
Cardiovascular Events
The HRs ranged from 1.14 (P=0.0020) 48 to 1.81 (P=0.0018). 28 Of these 11 HRs, 7 were significant. [26] [27] [28] [29] 31, 48, 49 The HR combing all the cohorts (Figure 3 
Night-to-Day Blood Pressure Ratio Total Mortality
The HRs expressing the risk of death associated with the night-to-day blood pressure ratio ranged from 1.06 (P=0.45) 48 to 1.86 (P=0.0079). 28 Of these 11 HRs, 3 were significant. 27, 28, 49 The pooled HR (Figure 3 , Panel A) was 1.18 (CI, 1.10-1.26; P<0.0001). HRs with additional adjustment for the 24-h blood pressure ranged from 1.05 (P=0.53) 48 to 1.77 (P=0.014). 28 Of these 11 fully adjusted HRs, 3 were significant. 27, 28, 49 The HR combining all the cohorts (Figure 3, Panel B 28 Of these 11 fully adjusted HRs, only 2 were significant. 27, 49 The HR combining all the cohorts (Figure 3, Panel B ) was 1.08 (CI, 1.01-1.16; P=0.029).
Dipping status Total Mortality
Across the 11 cohorts (Table S5) , the HRs expressing the risk of death associated with nondipping ranged from 1.02 (P=0.96) 30 to 2.51 (P=0.11), 28 but only 1 was significant. 27 The pooled HR ( Figure  3 , Panel A) was 1.26 (CI, 1.11-1.44; P=0.0005). HRs for the dipping status with additional adjustment for the 24-h blood pressure ranged from 1.01 (P=0.98) 30 to 2.41 (P=0.13), 28 but only 1 was significant. 27 The pooled fully adjusted HR (Figure 3, Panel B 28 Only 2 were significant. 27, 49 The pooled HR (Figure 3 *The basic Cox model was a stratified by cohort and adjusted for sex age, , body mass index, smoking and drinking, serum total cholesterol, history of cardiovascular disease, and diabetes mellitus. P-values are for the improvement of the fit across nested models. *The basic Cox model was stratified by cohort and adjusted for sex, age, body mass index, smoking and drinking, serum total cholesterol, history of cardiovascular disease, and diabetes mellitus. P-values are for the improvement of the fit across nested models.
